[1]
Ishiguro, N. et al. 2025. Entrectinib-induced Brugada syndrome leading to ventricular tachycardia in a patient with ROS1 fusion-positive lung adenocarcinoma. European Journal of Case Reports in Internal Medicine. 12, 5 (Apr. 2025). DOI:https://doi.org/10.12890/2025_005232.